Search for: "PFIZER"
Results 2801 - 2820
of 4,635
Sort by Relevance
|
Sort by Date
27 Jan 2011, 8:22 am
These violators have nothing on Pfizer, however, who was required to pay $1.2 billion back to the federal government for its improper promotion of drugs it "forgot" to get approved by the Food & Drug Administration. [read post]
26 Jan 2011, 1:31 am
Pfizer paid $2.3 billion and pled guilty to misbranding the painkiller Bextra. [read post]
26 Jan 2011, 12:54 am
A.: The resolution in Pfizer is unique in many respects. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
25 Jan 2011, 11:20 am
Many drug companies including Johnson and Johnson, Lilly, Cephalon, Merck, Pfizer, and GlaxoSmithKline have paid more than $257.8 million to doctors since 2009. [read post]
24 Jan 2011, 1:59 am
Time will tell how that works out.As frustrating as attempts to control E. coli in feedlots and on farms has been, Besser has seen some progress.For example, research has shown that some combinations of probiotic bacteria strains can be effective in controlling E. coli while also improving cattle health.Probiotics are live microorganisms such as those in some yogurts and diet supplements that have been shown to be beneficially healthy, especially in the intestinal tract.Besser also said the vaccine… [read post]
23 Jan 2011, 10:01 pm
20 Jan 2011, 12:50 pm
We blogged about the highly suspect decision in Centocor, Inc. v. [read post]
19 Jan 2011, 1:30 pm
As a result of Pfizer's negligence to inform the general public about the potentially deadly side effects, the St. [read post]
19 Jan 2011, 2:00 am
(Spicy IP) India: Delhi Patent Office refuses Warner-Lambert’s application claiming topical formulation of Pfizer’s potential potassium channel opener for treatment of alopecia (ipfeathers) India: Chennai Patent Office refuses Novartis’ application claiming mixture of anti-oxidant with oxidation sensitive macrolide everolimus (ipfeathers) Kenya: High Court enjoins UN in case against generic ARVs ban (GenericsWeb) US government urges WHO to support Medicines Patent Pool:… [read post]
19 Jan 2011, 1:59 am
In addition to Sulfadimethoxine, the dairy's use of Penicillin G Procaine and Ceftiofur, another antibiotic, was questioned by FDA.FDA said the penicillin and ceftiofur, originally provided by Pfizer in the late 1980s and marketed as Excede, were not being used as directed by the label. [read post]
18 Jan 2011, 11:22 pm
The Delhi Patent Office lately refused the Application Number 4015/DELNP/2006 filed by Warner Lambert claiming topical formulation of Pfizer’s potential potassium channel opener UK-157147 for the treatment of alopecia, which got discontinued in phase II trials. [read post]
18 Jan 2011, 11:22 pm
The Delhi Patent Office lately refused the Application Number 4015/DELNP/2006 filed by Warner Lambert claiming topical formulation of Pfizer’s potential potassium channel opener UK-157147 for the treatment of alopecia, which got discontinued in phase II trials. [read post]
17 Jan 2011, 9:27 am
In Pfizer Inc. v. [read post]
14 Jan 2011, 8:17 am
Davos Imposes 20% Gender Quota on Participating Businesses The Week's Most Widely-Read NYT Article: The Real Story on the Post-Law School Employment Statistics Pfizer's Amy Schulman, One Year After the End of the Billable Hour Yale Law Professor Amy Chua Brings Back My Nightmares about Kumon with her WSJ Article, "Why Chinese Mothers Are Superior" FDNY Must Revamp Hiring Exams and Procedures After Successful Race Discrimination Suit Congratulations to 2010 Writer in… [read post]
12 Jan 2011, 12:08 am
AmLaw Daily has a brief update on the Pfizer General Counsel Amy Schulman's innovative approach to retaining and evaluating a core group of law firms. [read post]
11 Jan 2011, 11:07 pm
Senators follow House colleagues in making BPCIA exclusivity clarifications; New study suggests benefits of longer drug exclusivity period (FDA Law Blog) US: BPCIA’s principal authors seek to clarify Congressional intent with respect to 12-year exclusivity period; PhRMA/BIO request ‘umbrella exclusivity’ (FDA Law Blog) US: BIO’s IP priorities for 2011 (PatentlyBIOtech) US: BIO survey shows support for DNA-based patents despite some reservations (Patent Docs) US:… [read post]
10 Jan 2011, 3:50 pm
Amy Schulman set out to reform the lawyer-client relationship. [read post]
8 Jan 2011, 1:59 am
After acquiring worldwide rights to the promising E. coli O157:H7 vaccine, Pfizer Animal Health is putting its considerable marketing clout behind the only product known for reducing E. coli O157 shedding and prevalence at the source, inside the cattle.Madison, NJ-based Pfizer Animal Health acquired global rights for the vaccine in 2010 from Epitopix LLC and early 2011 finds its pushing the product as "an exciting new opportunity for the beef industry," according to… [read post]
7 Jan 2011, 8:55 am
Megasettlements of Shareholders’ Derivative Lawsuits Surge: The emergence of large settlements of shareholders derivative lawsuits, including the $90 million AIG/Greenberg settlement and the $75 million Pfizer settlement. [read post]
